Hope in Focus to Host LCA Family Conference June 23-24
/PRNewswire/ -- Hope in Focus, a nonprofit dedicated to finding treatments and cures for blindness caused by rare inherited retinal diseases, presents its 2023...
Source: prnewswire.com
Stay updated with breaking news from Wiley Chambers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Hope in Focus, a nonprofit dedicated to finding treatments and cures for blindness caused by rare inherited retinal diseases, presents its 2023...
Teprotumumab, a minimally invasive insulin-like growth factor I blocking antibody, has been shown to enhance symptoms, appearance, and quality of life in patients with thyroid eye disease, according to a study.
Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in their